View in EDS HTML Full Text PDF Full Text

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Saved in:
Bibliographic Details
Title: Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.
Authors: Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore., Fong KY; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore., Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore., Tey J; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore., Dawood S; Department of Medical Oncology, Mediclinic City Hospital, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai 505055, United Arab Emirates., Lee SC; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore., Finn RS; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA., Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169547, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore 117456, Singapore.; Singapore Gastric Cancer Consortium, Singapore 119074, Singapore., Lim JSJ; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore.
Source: Cancers [Cancers (Basel)] 2023 Sep 14; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 14.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37760527
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+JJ%22">Zhao JJ</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.<br /><searchLink fieldCode="AU" term="%22Fong+KY%22">Fong KY</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.<br /><searchLink fieldCode="AU" term="%22Chan+YH%22">Chan YH</searchLink>; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.<br /><searchLink fieldCode="AU" term="%22Tey+J%22">Tey J</searchLink>; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.<br /><searchLink fieldCode="AU" term="%22Dawood+S%22">Dawood S</searchLink>; Department of Medical Oncology, Mediclinic City Hospital, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai 505055, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore.<br /><searchLink fieldCode="AU" term="%22Finn+RS%22">Finn RS</searchLink>; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA.<br /><searchLink fieldCode="AU" term="%22Sundar+R%22">Sundar R</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169547, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore 117456, Singapore.; Singapore Gastric Cancer Consortium, Singapore 119074, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JSJ%22">Lim JSJ</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2023 Sep 14; Vol. 15 (18). <i>Date of Electronic Publication: </i>2023 Sep 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37760527
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers15184558
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao JJ
      – PersonEntity:
          Name:
            NameFull: Fong KY
      – PersonEntity:
          Name:
            NameFull: Chan YH
      – PersonEntity:
          Name:
            NameFull: Tey J
      – PersonEntity:
          Name:
            NameFull: Dawood S
      – PersonEntity:
          Name:
            NameFull: Lee SC
      – PersonEntity:
          Name:
            NameFull: Finn RS
      – PersonEntity:
          Name:
            NameFull: Sundar R
      – PersonEntity:
          Name:
            NameFull: Lim JSJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 09
              Text: 2023 Sep 14
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 18
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1